{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:51:49Z","timestamp":1791139909233,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":776,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.jval.2010.11.015","type":"journal-article","created":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T10:10:39Z","timestamp":1308823839000},"page":"492-498","source":"Crossref","is-referenced-by-count":11,"title":["Economic Impact of Nonpersistence with Antidepressant Treatment in the Adult Population of Quebec: A Comparative Cost-Effectiveness Approach"],"prefix":"10.1016","volume":"14","author":[{"given":"Sarah-Gabrielle","family":"B\u00e9land","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Galbaud du Fort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Crott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Ducruet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yola","family":"Moride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2010.11.015_bib1","first-page":"11","article-title":"Depression","volume":"7","author":"Beaudet","year":"1996","journal-title":"Health Rep"},{"key":"10.1016\/j.jval.2010.11.015_bib2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.62.10.1097","article-title":"Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions","volume":"62","author":"Hasin","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib3","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2010.11.015_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib5","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(05)66665-2","article-title":"Depression in the elderly","volume":"365","author":"Alexopoulos","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2010.11.015_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biopsych.2005.04.024","article-title":"Executive dysfunction and the course of geriatric depression","volume":"58","author":"Alexopoulos","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1532-5415.2002.50063.x","article-title":"Geriatric depression, antidepressant treatment, and healthcare utilization in a health maintenance organization","volume":"50","author":"Fischer","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jval.2010.11.015_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-1781(96)02964-2","article-title":"Two-year outcome of elderly patients with anxious depression","volume":"66","author":"Flint","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jval.2010.11.015_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(03)12599-8","article-title":"Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review","volume":"361","author":"Geddes","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2010.11.015_bib10","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-132-9-200005020-00010","article-title":"Pharmacologic treatment of acute major depression and dysthymia","volume":"132","author":"Snow","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2010.11.015_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archpsyc.1992.01820100075013","article-title":"The course, morbidity, and costs of depression","volume":"49","author":"Klerman","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archpsyc.55.12.1128","article-title":"The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression","volume":"55","author":"Melfi","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.61.11.1097","article-title":"The burden of major depression avoidable by longer-term treatment strategies","volume":"61","author":"Vos","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-199201000-00007","article-title":"Adequacy and duration of antidepressant treatment in primary care","volume":"30","author":"Katon","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2010.11.015_bib16","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1046\/j.1532-5415.2002.50357.x","article-title":"Suboptimal duration of antidepressant treatments in the older ambulatory population of Quebec: association with selected physician characteristics","volume":"50","author":"Moride","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jval.2010.11.015_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0163-8343(93)90009-D","article-title":"Patterns of antidepressant use in community practice","volume":"15","author":"Simon","year":"1993","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib18","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1056\/NEJMsa022615","article-title":"The quality of health care delivered to adults in the United States","volume":"348","author":"McGlynn","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2010.11.015_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1176\/appi.ajp.163.1.101","article-title":"Continuity of antidepressant treatment for adults with depression in the United States","volume":"163","author":"Olfson","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-2007-979323","article-title":"Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression","volume":"31","author":"Moller","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib21","first-page":"1245","article-title":"Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis","volume":"159","author":"Trindade","year":"1998","journal-title":"CMAJ"},{"key":"10.1016\/j.jval.2010.11.015_bib22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/gps.1156","article-title":"A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis","volume":"19","author":"Wilson","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mhp.95","article-title":"Antidepressant treatment for depression: total charges and therapy duration","volume":"3","author":"Dobrez","year":"2000","journal-title":"J Ment Health Policy Econ"},{"key":"10.1016\/j.jval.2010.11.015_bib24","first-page":"453","article-title":"Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environments","volume":"3","author":"Fairman","year":"1997","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jval.2010.11.015_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00004850-199400910-00008","article-title":"Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates","volume":"9","author":"Montgomery","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jval.2010.11.015_bib26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1345\/aph.1A331","article-title":"Increased use of antidepressants in Canada: 1981\u20132000","volume":"36","author":"Hemels","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jval.2010.11.015_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.157.3.360","article-title":"Use of antidepressants among elderly subjects: trends and contributing factors","volume":"157","author":"Mamdani","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0447.1998.tb09995.x","article-title":"Economic comparisons of the pharmacotherapy of depression: an overview","volume":"97","author":"Crott","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jval.2010.11.015_bib29","author":"Dreyer"},{"issue":"Suppl. 12","key":"10.1016\/j.jval.2010.11.015_bib30","first-page":"S354","article-title":"Differences in total medical costs across the SSRIs for the treatment of depression and anxiety","volume":"11","author":"Sheehan","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jval.2010.11.015_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1185\/030079906X80314","article-title":"Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study","volume":"22","author":"Monfared","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jval.2010.11.015_bib32","first-page":"24","article-title":"Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxiety","volume":"15","author":"Wan","year":"2002","journal-title":"Manag Care Interface"},{"key":"10.1016\/j.jval.2010.11.015_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1524-4733.2001.44084.x","article-title":"Long-term costs of treatment for depression: impact of drug selection and guideline adherence","volume":"4","author":"Crown","year":"2001","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2010.11.015_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.v63n0212","article-title":"Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans","volume":"63","author":"Polsky","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jval.2010.11.015_bib35","first-page":"597","article-title":"Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline","volume":"5","author":"Russell","year":"1999","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jval.2010.11.015_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jad.2008.07.004","article-title":"Economical impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population","volume":"115","author":"Tournier","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jval.2010.11.015_bib37","doi-asserted-by":"crossref","first-page":"492","DOI":"10.18553\/jmcp.2002.8.6.492","article-title":"Economic evaluation of citalopram use and expenditures among recipients in the Texas Medicaid program","volume":"8","author":"Johnsrud","year":"2002","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jval.2010.11.015_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1099-1557(199707)6:4<235::AID-PDS293>3.0.CO;2-3","article-title":"A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies","volume":"6","author":"Mackay","year":"1997","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jval.2010.11.015_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clinthera.2006.02.006","article-title":"Comparison of first refill rates among users of sertraline, paroxetine, and citalopram","volume":"28","author":"Mullins","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.jval.2010.11.015_bib40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1592\/phco.25.5.660.63590","article-title":"Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram","volume":"25","author":"Mullins","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jval.2010.11.015_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1022533118031","article-title":"Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization","volume":"30","author":"Sheffield","year":"2002","journal-title":"Adm Policy Ment Health"},{"key":"10.1016\/j.jval.2010.11.015_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1520-6394(1998)7:2<53::AID-DA1>3.0.CO;2-6","article-title":"Health economic evaluations of antidepressants: a review","volume":"7","author":"Hylan","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jval.2010.11.015_bib43","first-page":"173","article-title":"Cost-effective treatment of depression with selective serotonin reuptake inhibitors","volume":"7","author":"Panzarino","year":"2001","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jval.2010.11.015_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0149-2918(04)90012-4","article-title":"A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: impact on depression-related treatment charges","volume":"26","author":"McLaughlin","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.jval.2010.11.015_bib45","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1345\/aph.1A254","article-title":"Discontinuing or switching selective serotonin-reuptake inhibitors","volume":"36","author":"Bull","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jval.2010.11.015_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-199501000-00006","article-title":"The role of the primary care physician in patients' adherence to antidepressant therapy","volume":"33","author":"Lin","year":"1995","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2010.11.015_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0895-4356(92)90016-G","article-title":"A chronic disease score from automated pharmacy data","volume":"45","author":"Von Korff","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jval.2010.11.015_bib48","series-title":"Logistic regression using the SAS system \u2013 Theory and application","author":"Allison","year":"1999"},{"key":"10.1016\/j.jval.2010.11.015_bib49","series-title":"Evaluation clinique et \u00e9conomique des inhibiteurs sp\u00e9cifiques du recaptage de la s\u00e9rotonine dans les cas de d\u00e9pression grave","year":"1998"},{"key":"10.1016\/j.jval.2010.11.015_bib50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2165\/00003495-199957040-00005","article-title":"Systematic review and guide to selection of selective serotonin reuptake inhibitors","volume":"57","author":"Edwards","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.jval.2010.11.015_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0327(99)00147-0","article-title":"The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared","volume":"59","author":"Lawrenson","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jval.2010.11.015_bib53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1377\/hlthaff.28.3.783","article-title":"Improving mental health treatments through comparative effectiveness research","volume":"28","author":"Wang","year":"2009","journal-title":"Health Affairs"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T05:39:19Z","timestamp":1637905159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301510000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1098301510000859"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2010.11.015","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}